calendar
7,405 catalysts · 3,350 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k
7,405 catalysts · 3,350 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k
Vue Motion V12. Product Number: 1017979. — Reason: Potential that mis-ordered frames in Vue Motion during dynamic cine runs may cause images frames to display out of sequence. — Status: Ongoing
GM grant. $409,941. PI: Aaron Harvey Morris
MH grant. $442,750. PI: Lauren Marie Schaefer
HL grant. $44,751. PI: Abhishek Vijay Thakkar
CA grant. $550,210. PI: Shawn Hingtgen
GM grant. $406,112. PI: Jie Sun
GM grant. $406,026. PI: Yaojun Zhang
GM grant. $432,569. PI: Simou Sun
EB grant. $662,737. PI: Yanliang Zhang
DC grant. $2,387,184. PI: JACK M FLETCHER
MH grant. $208,794. PI: Emily Lauren Tilstra-Ferrell
DE grant. $555,081. PI: Christina Scherrer
MH grant. $445,816. PI: Jennifer Blumenthal-Barby
GM grant. $123,687. PI: Owen Funk
MH grant. $843,322. PI: Ragy Ramsis Girgis
AG grant. $214,223. PI: Robert Edward Burke
OD grant. $434,110. PI: Jenni Shearston
MH grant. $710,563. PI: Christine M Constantinople
GM grant. $433,125. PI: Amy C Rowat
GM grant. $449,625. PI: Samagya Banskota
DK grant. $655,482. PI: VIKAS DUDEJA
NS grant. $75,880. PI: Christopher David Adam
MH grant. $641,828. PI: Hume Akahori Stroud
AG grant. $121,239. PI: Mara Getz Sheftel
MH grant. $820,196. PI: Stephen P Becker
MH grant. $779,797. PI: Rainbo Hultman
NS grant. $555,265. PI: Emily Rose Petrus
MH grant. $659,242. PI: Hyman Scott
DC grant. $124,686. PI: Eleonora Judith Beier
MH grant. $156,500. PI: Santiago Jose Arconada Alvarez
GM grant. $445,983. PI: Mark A PERRELLA
GM grant. $429,000. PI: Lauren Elizabeth Surface
GM grant. $407,603. PI: Grayson Oren Sipe
NS grant. $602,065. PI: J. Marc Simard
Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: ABBVIE INC. Form: INJECTABLE. Route: INJECTION
Sponsor: UPSHER SMITH LABS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: APHELION. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL
Sponsor: VIVUS LLC. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL
Sponsor: JANSSEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: PFIZER. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: JANSSEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: BRISTOL. Form: TABLET. Route: ORAL
Sponsor: SUPERNUS PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL